Abstract:Normal tension glaucoma (NTG) is a multifactorial optic neuropathy characterized by normal intraocular pressure, progressive retinal ganglion cell (RGC) death, and glaucomatous visual field loss. Recent studies have described the mechanisms underlying the pathogenesis of NTG. In addition to controlling intraocular pressure, neuroprotection and reduction of RGC degeneration may be beneficial therapies for NTG. In this review, we summarized the main regulatory mechanisms of RGC death in NTG, including autophagy, glutamate neurotoxicity, oxidative stress, neuroinflammation, immunity, and vasoconstriction. Autophagy can be induced by retinal hypoxia and axonal damage. In this process, ischemia can cause mutations of optineurin and activate the nuclear factor-kappa B pathway. Glutamate neurotoxicity is induced by the over-stimulation of N-methyl-D-aspartate membrane receptors by glutamate, which occurs in RGCs and induces progressive glaucomatous optic neuropathy. Oxidative stress also participates in NTG-related glaucomatous optic neuropathy. It impairs the mitochondrial and DNA function of RGCs through the apoptosis signal-regulating kinase-JUN N-terminal kinase pathway. Moreover, it increases inflammation and the immune response of RGCs. Endothelin 1 causes endothelial dysfunction and impairment of ocular blood flow, promoting vasospasm and glaucomatous optic neuropathy, as a result of NTG. In conclusion, we discussed research progress on potential options for the protection of RGCs, including TANK binding kinase 1 inhibitors regulating autophagy, N-methyl-D-aspartate receptor antagonists inhibiting glutamate toxicity, ASK1 inhibitors regulating mitochondrial function, and antioxidants inhibiting oxidative stress. In NTG, RGC death is regulated by a network of mechanisms, while various potential targets protect RGCs. Collectively, these findings provide insight into the pathogenesis of NTG and potential therapeutic strategies.

Apoptosis in glaucoma: A new direction for the treatment of glaucoma (Review)

Recent Advances on the Apoptosis of Glaucoma Retinal Ganglion Cells

Autophagy in glaucoma pathogenesis: Therapeutic potential and future perspectives

Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis

Retinal ganglion cell death is triggered by paraptosis via reactive oxygen species production: a brief literature review presenting a novel hypothesis in glaucoma pathology.

Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats

Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies

Mutual Regulation of the Hippo/Wnt/LPA/TGF‑β Signaling Pathways and Their Roles in Glaucoma (Review)

Glial Cell and Glaucomatous Optic Neuropathy

Protection of retinal ganglion cells in glaucoma: Current status and future

Therapeutic strategies for glaucoma and optic neuropathies

Progress in glaucoma retinal ganglion cells injury

Autophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model

Glaucoma: Biological Mechanism and its Clinical Translation

Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology

Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies

Mitochondrial dysfunction in glaucomatous degeneration

Think highly of fundamental dilemma in glaucomatous neuroprotection research

Advances in gene therapy for glaucoma

From Bench to Bed: the Current Genome Editing Therapies for Glaucoma

Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptors